Activity of novel non-amphipathic cationic antimicrobial peptides against Candida species

The Journal of Antimicrobial Chemotherapy
Lori L BurrowsCharles M Deber

Abstract

Candida species are problematic opportunistic pathogens in the hospital setting, where they are frequently associated with opportunistic infections of indwelling medical devices. There are only a few effective classes of antifungal agents currently available, and some species, such as Candida lusitaniae, Candida glabrata and Candida krusei, are intrinsically resistant to some of these drugs, further reducing existing therapeutic options. We have recently developed synthetic, non-amphipathic cationic antimicrobial peptides (CAPs) based on the structure of native hydrophobic membrane-spanning domains of integral membrane proteins. In this article, we report on the activity of these CAPs and new variants thereof against eight Candida species. Using a combination of MIC, haemolysis, time-kill and biofilm killing assays, we demonstrate activity of CAPs in the micromolar range against eight Candida species, with little toxicity to mammalian cells. The synthetic peptides killed both the fluconazole-susceptible and fluconazole-resistant strains of Candida albicans, Candida tropicalis and C. glabrata by 4 logs or more within 3 h, and also killed pre-formed yeast biofilms on plastic surfaces. These peptides show promise as a basis for de...Continue Reading

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J Y LeeH G Boman
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Zasloff
Jan 1, 1994·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·H Vanden BosscheO Ronin
Jan 27, 1994·The New England Journal of Medicine·J A Como, W E Dismukes
Sep 1, 1995·Antimicrobial Agents and Chemotherapy·S P Hawser, L J Douglas
Oct 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S P Fisher-Hoch, L Hutwagner
Jun 1, 1997·Infectious Disease Clinics of North America·W L Wright, R P Wenzel
Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D PittetR P Wenzel
Dec 31, 1998·Antimicrobial Agents and Chemotherapy·A J De Lucca, T J Walsh
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·A BroounK Lewis
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M M McNeilD W Warnock
Jun 5, 2002·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Thomas R Rogers
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·Margareta StarkCharles M Deber
Jan 16, 2003·Trends in Microbiology·L Julia Douglas
Oct 18, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L Ostrosky-ZeichnerJ H Rex
Oct 24, 2003·The Journal of Hospital Infection·R P Hobson
Nov 19, 2003·Pharmacotherapy·Annie Wong-Beringer, Jane Kriengkauykiat
Apr 16, 2004·Clinical Microbiology Reviews·Erna M Kojic, Rabih O Darouiche
Jun 5, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A M L Oude LashofUNKNOWN EORTC Invasive Fungal Infections Group
Apr 2, 2005·Biotechnology and Bioengineering·Nebojsa M MilovićAlexander M Klibanov
Jul 5, 2005·Biomaterials·Mark J ErnstingJ Paul Santerre
Dec 1, 1999·Mycoses·F-M C MüllerT J Walsh

❮ Previous
Next ❯

Citations

Mar 8, 2013·Future Medicinal Chemistry·Derry K Mercer, Deborah A O'Neil
May 13, 2015·Scientific Reports·Kah Yean LumShamala Devi Sekaran
Aug 16, 2015·Cytokine·Natasha Whibley, Sarah L Gaffen
Jan 27, 2018·Journal of Fungi·Małgorzata BondarykZofia Urbańczyk-Lipkowska
Apr 23, 2014·Antimicrobial Agents and Chemotherapy·Lisa K RyanGill Diamond
Jan 11, 2008·Biopolymers·Evgenia GlukhovCharles M Deber
Jul 12, 2013·FEMS Microbiology Letters·Sarah R DennisonDavid A Phoenix
Jul 3, 2019·Journal of Peptide Science : an Official Publication of the European Peptide Society·Hamid MadanchiSoroush Sardari
May 31, 2018·Journal of Peptide Science : an Official Publication of the European Peptide Society·Christophe LabrièreJohan Svenson
Nov 5, 2019·Frontiers in Microbiology·Karen G N OshiroOctávio Luiz Franco
Apr 8, 2020·Frontiers in Cellular and Infection Microbiology·Miguel Fernández de UllivarriPaul D Cotter
Sep 1, 2019·Comprehensive Reviews in Food Science and Food Safety·Thibaut TheryElke K Arendt
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Harinash RaoPei Pei Chong
Jul 6, 2021·Frontiers in Chemistry·Tanumoy SarkarSunanda Chatterjee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.